Current issues of selenium in cancer chemoprevention
暂无分享,去创建一个
[1] Y. Seo,et al. Enhancement of methyl methanesulfonate-induced base excision repair in the presence of selenomethionine on p53-dependent pathway. , 2009, Journal of medicinal food.
[2] Hongbo Hu,et al. Methyl-Selenium Compounds Inhibit Prostate Carcinogenesis in the Transgenic Adenocarcinoma of Mouse Prostate Model with Survival Benefit , 2009, Cancer Prevention Research.
[3] L. Klotz,et al. A Combination of Micronutrients Is Beneficial in Reducing the Incidence of Prostate Cancer and Increasing Survival in the Lady Transgenic Model , 2009, Cancer Prevention Research.
[4] M. Gail,et al. Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. , 2009, Journal of the National Cancer Institute.
[5] V. Gladyshev,et al. The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology. , 2009, Molecular interventions.
[6] J. Crowley,et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). , 2009, JAMA.
[7] G. Combs,et al. Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. , 2008, Carcinogenesis.
[8] R. Sinha,et al. Effects of Naturally Occurring and Synthetic Organoselenium Compounds on Protein Profiling in Androgen Responsive and Androgen Independent Human Prostate Cancer Cells , 2008, Nutrition and cancer.
[9] Sung-Hoon Kim,et al. Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density , 2008, International journal of cancer.
[10] Ruiwen Wang,et al. Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates , 2007, Molecular Cancer Therapeutics.
[11] K. Pollok,et al. Chemotherapeutic selectivity conferred by selenium: a role for p53-dependent DNA repair , 2007, Molecular Cancer Therapeutics.
[12] A. Favier,et al. Antioxidant status and lipid peroxidation in athymic mice xenografted with two types of human tumors , 2007, Biological Trace Element Research.
[13] S. Amin,et al. The organoselenium compound 1,4-phenylenebis(methylene)selenocyanate inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorgenesis and enhances glutathione-related antioxidant levels in A/J mouse lung. , 2006, Chemico-biological interactions.
[14] V. Ray,et al. Selenoprotein deficiency accelerates prostate carcinogenesis in a transgenic model. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[15] Cheng Jiang,et al. Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway , 2006, Molecular Cancer Therapeutics.
[16] C. Davis,et al. Both selenoproteins and low molecular weight selenocompounds reduce colon cancer risk in mice with genetically impaired selenoprotein expression , 2006, The Journal of nutrition.
[17] Yue Wu,et al. Delineating the mechanism by which selenium deactivates Akt in prostate cancer cells , 2006, Molecular Cancer Therapeutics.
[18] T. Bihani,et al. Enhanced selenium effect on growth arrest by BiP/GRP78 knockdown in p53-null human prostate cancer cells , 2006, Oncogene.
[19] Yue Wu,et al. Endoplasmic reticulum stress signal mediators are targets of selenium action. , 2005, Cancer research.
[20] Cheng Jiang,et al. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells. , 2005, Carcinogenesis.
[21] D. Bostwick,et al. Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model. , 2005, Carcinogenesis.
[22] M. Ringnér,et al. Microarray Data Mining for Potential Selenium Targets in Chemoprevention of Prostate Cancer. , 2005 .
[23] M. Rayman. The use of high-selenium yeast to raise selenium status: how does it measure up? , 2004, British Journal of Nutrition.
[24] I. Thompson,et al. Update on chemoprevention of prostate cancer , 2004, Current opinion in urology.
[25] Martin L. Smith,et al. Selenium compounds regulate p53 by common and distinctive mechanisms. , 2004, Anticancer research.
[26] P. Whanger. Selenium and its relationship to cancer: an update† , 2004, British Journal of Nutrition.
[27] H. Ganther,et al. New Concepts in Selenium Chemoprevention , 2004, Cancer and Metastasis Reviews.
[28] S. Amin,et al. Comparison of the Chemopreventive Efficacies of 1,4-phenylenebis(methylene)selenocyanate and Selenium-Enriched Yeast on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Induced Lung Tumorigenesis in A/J Mouse , 2003, Nutrition and cancer.
[29] I. Thompson,et al. The Selenium and Vitamin E Cancer Prevention Trial , 2003, World Journal of Urology.
[30] Y. Seo,et al. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[31] B. Turnbull,et al. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[32] Y. Seo,et al. Selenomethionine induction of DNA repair response in human fibroblasts , 2002, Oncogene.
[33] Z. Wang,et al. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling. , 2001, Cancer research.
[34] K. El-Bayoumy,et al. The protective role of selenium on genetic damage and on cancer. , 2001, Mutation research.
[35] A. Bhattacharyya,et al. The effects of dietary selenomethionine on polyamines and azoxymethane-induced aberrant crypts. , 2000, Cancer letters.
[36] H. Ganther,et al. Chemoprevention with triphenylselenonium chloride in selenium-deficient rats. , 2000, Anticancer research.
[37] M. Rayman,et al. The importance of selenium to human health , 2000, The Lancet.
[38] H. Ganther,et al. Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[39] Cheng Jiang,et al. Selenium‐induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake , 1999, Molecular carcinogenesis.
[40] H. Ganther,et al. Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat. , 1999, Anticancer research.
[41] H. Ganther,et al. Activities of structurally-related lipophilic selenium compounds as cancer chemopreventive agents. , 1998, Anticancer research.
[42] G. Combs,et al. Chemopreventive agents: selenium. , 1998, Pharmacology & therapeutics.
[43] B. Turnbull,et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. , 1998, British journal of urology.
[44] H. Ganther,et al. Cytostasis and cancer chemoprevention: investigating the action of triphenylselenonium chloride in in vivo models of mammary carcinogenesis. , 1998, Anticancer research.
[45] H. Ganther,et al. Triphenylselenonium and diphenylselenide in cancer chemoprevention: comparative studies of anticarcinogenic efficacy, tissue selenium levels and excretion profile. , 1997, Anticancer research.
[46] Bruce W. Turnbull,et al. Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin: A Randomized Controlled Trial , 1996 .
[47] G. Omenn,et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.
[48] S. Marklund,et al. Levels of selenium in plasma and glutathione peroxidase in erythrocytes in patients with prostate cancer or benign hyperplasia. , 1995, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[49] M. Torun,et al. Serum selenium levels in various cancer types , 1995 .
[50] H. Ganther,et al. Activity of triphenylselenonium chloride in mammary cancer prevention. , 1994, Carcinogenesis.
[51] D. Albanes,et al. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.
[52] H. Ganther,et al. Metabolites of sodium selenite and methylated selenium compounds administered at cancer chemoprevention levels in the rat. , 1993, Xenobiotica; the fate of foreign compounds in biological systems.
[53] H. Ganther,et al. Comparison of selenium and sulfur analogs in cancer prevention. , 1992, Carcinogenesis.
[54] M. Criqui,et al. Selenium, retinol, retinol-binding protein, and uric acid. Associations with cancer mortality in a population-based prospective case-control study. , 1991, Annals of epidemiology.
[55] H. Ganther,et al. Chemical form of selenium, critical metabolites, and cancer prevention. , 1991, Cancer research.
[56] Clark Lc. The epidemiology of selenium and cancer. , 1985 .
[57] G. Duggin,et al. Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer. , 1984, Cancer research.
[58] W. Mertz. The essential trace elements. , 1981, Science.